Acción ORTX ORCHARD THERAPEUTICS PLC
Añadir a una lista
Para utilizar esta función debe ser un cliente o miembro.
ConéctateRegístrate
Instrumento Inactivo

Otros idiomas Orchard Therapeutics plc

Acciones

ORTX

US68570P2002

Otros idiomas

Buscar
Ver los resultados
Desbloquee todas las noticias sobre todas las empresas: ¡No vuelvas a perderse una oportunidad de inversión rentable!
Inscripción 100% Gratuita
FDA Approves First Gene Therapy To Treat Children With Metachromatic Leukodystrophy
FDA approves innovative gene therapy for MLD
Orchard Therapeutics Outlines U.S. Launch Plans for Lenmeldy™ (atidarsagene autotemcel), the Only Approved Therapy for Children with Early-onset Metachromatic Leukodystrophy
Orchard Therapeutics Receives FDA Approval of Lenmeldy™ (atidarsagene autotemcel), the Only Therapy for Eligible Children with Early-onset Metachromatic Leukodystrophy in the U.S.
Orchard Therapeutics Receives FDA Approval of Lenmeldy? (atidarsagene autotemcel)
Orchard Therapeutics Announces First Patient Randomized in Registrational Trial of OTL-203 for MPS-I Hurler Syndrome
Orchard Therapeutics Announces First Patient Randomized in Registrational Trial of OTL-203 for MPS-I Hurler Syndrome
Orchard Therapeutics Announces Multiple Presentations at the 20th Annual WORLDSymposium
Kyowa Kirin Co., Ltd - Notice regarding Completion of Share Acquisition of Orchard Therapeutics plc
Japanese Shares Skid as Inflation Slows Faster-than-Expected in January
Kyowa Kirin Acquires All Outstanding Shares of Orchard Therapeutics
Orchard Therapeutics Announces Agreement with the Beneluxa Consortium Enabling Reimbursed Access to Libmeldy
Orchard Therapeutics plc Announces Board Changes
Orchard Therapeutics Completes Sale to Japan's Kyowa Kirin
Kyowa Kirin successfully completes acquisition of Orchard Therapeutics, a global gene therapy leader for rare diseases
Orchard Therapeutics plc(NasdaqCM:ORTX) dropped from NASDAQ Composite Index
Kyowa Kirin Co., Ltd. completed the acquisition of Orchard Therapeutics plc from RA Capital Management, L.P., Deep Track Capital, LP, Zentree Investment Management Pte. Ltd. and others.
Orchard Therapeutics’ Gene Therapy Gets Swiss Regulatory Approval
Orchard Therapeutics Receives Swissmedic Approval for Libmeldy in Early-onset MLD
Orchard Therapeutics Receives Swiss Agency for Therapeutic Products Approval for Libmeldy in Early-Onset Metachromatic Leukodystrophy
No hay resultados para esta búsqueda
Todas Recomendaciones analistas Eventos destacados Insiders Transcripts Comunicados Publs. oficiales Otros idiomas Ideas de trading Artículos de MarketScreener Estrategias MarketScreener

Filtros

Buscar

Fecha de publicación

De

Hasta

  1. Bolsa de valores
  2. Acciones
  3. Acción ORTX
  4. Noticias Orchard Therapeutics plc
  5. Otros idiomas